Surgery, anesthesia, and opioid pain medications all slow GI transit
The spillover effect of GLP-1s may further influence nutrition in ways that eventually eliminate the need for GLP-1 intervention
In Part 1 we started discussing the study Two Years After Stopping GLP-1s, Most Patients Sustain at Least Some Weight Loss by Bartelt et al
This helped patients get the treatment they needed without stopping, although its not known how well oral tirzepatide works
[11] Tompkins, S.C., Sheldon, R.D., Rauckhorst, A.J., Noterman, M.F., Solst, S.R., Buchanan, J.L